Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia

Psychiatry Research

Volumn 102, Issue 1, 2001, Pages 49-57

  Poyurovsky, Michael ^a,e   Hramenkov, Sophia ^b   Isakov, Victoria ^b   Rauchverger, Boris ^b   Modai, Ilan ^b,e   Schneidman, Michael ^a,e   Fuchs, Camil ^d   Weizman, Abraham ^c,d  

^a Technion Medical School   (Israel)

^b SHA'AR MENASHE MENTAL HEALTH CENTER   (Israel)

^c GPHFMRC   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Chronic schizophrenia; Hospitalized patients; Obsessive compulsive disorder (OCD)

Indexed keywords

CLOZAPINE; FLUOXETINE; FLUVOXAMINE; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RATING SCALE; SCHIZOPHRENIA; SOCIAL STATUS; SYMPTOM;

ADULT; CHRONIC DISEASE; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SCHIZOPHRENIA;

EID: 0035837248     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(01)00238-4     Document Type: Article

References (35)

1. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS). 1983;The University of Iowa, Iowa City, IA.
2. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS). 1984;University of Iowa, Iowa City, IA.
3. Barnes T.R.E. A rating scale for drug-induced akathisia. British Journal of Psychiatry. 154:1989;672-676.
4. Berman I., Kalinowksi A., Berman S., Lengua J., Green A. Obsessions and compulsions in chronic schizophrenia. Comprehensive Psychiatry. 36:1995;6-10.
5. Berman I., Merson A., Viegner B., Losonczy M.F., Pappas D., Green A.J. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. Journal of Nervous and Mental Disease. 186:1998;150-156.
6. Bermanzohn P.C., Porto L., Arlow P.B., Pollack S., Stronger R., Siris S.G. Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophrenia Bulletin. 26:2000;517-525.
7. Bernie W.A., Litman S.K. Obsessionality in schizophrenia. Canadian Psychiatric Association Journal. 23:1978;77-81.
8. Cummings J.L. Frontal subcortical circuits and human behavior. Archives of Neurology. 50:1993;873-880.
9. Davis J.M. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry. 33:1976;858-861.
10. de Haan L., Linszen D.M., Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. Journal of Clinical Psychiatry. 60:1999;364-365.
11. Eisen J.L., Beer D.A., Pato M.T., Venditto T.A., Rasmussen S.A. Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. American Journal of Psychiatry. 154:1997;271-273.
12. Fenton W.S., McGlashan T.H. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. American Journal of Psychiatry. 143:1986;437-441.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structural Clinical Interview for Axis I DSM-IV DisordersPatient Edition (SCID-I/P, Version 2.0). 1994;Biometrics Research Department, New York State Psychiatric Institute.
14. Foa E.B., Kozak M.J. DSM-IV field trial: obsessive-compulsive disorder. American Journal of Psychiatry. 152:1995;90-96.
15. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleismann R.L., Hill C.L., Heninger G.R., Charney D.S. The Yale-Brown Obsessive-Compulsive Scale, II: validity. Archives of General Psychiatry. 46:1989;1012-1016.
16. Gordon A. Transition of obsessions into delusions: evaluation of obsessional phenomena from prognostic standpoint. American Journal of Psychiatry. 107:1950;455-458.
17. Guy W. ECDEU Assessment Manual for Psychopharmacology (rev. ed). 1976;US Department of Health, Education and Welfare, Washington, DC.
18. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 23:1960;56-62.
19. Harvey C.R., Curson D.A., Pantelis C., Taylor J., Barnes T.R. Four behavioural syndromes of schizophrenia. British Journal of Psychiatry. 168:1996;562-570.
20. Hwang M.Y., Morgan J.E., Losconzcy M.F. Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. Journal of Neuropsychiatry and Clinical Neuroscience. 12:2000;91-94.
21. Jahrreis W. Obsessions during schizophrenia. Archiv für Psychiatrie und Nervenkrankheiten (Berlin). 77:1926;740-788.
22. Kruger S., Braunig P., Hoffler J., Shugar G., Borner I., Langkrar J. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. Journal of Neuropsychiatry and Clinical Neuroscience. 12:2000;16-24.
23. Lysaker P.H., Marks K.A., Picone J.B., Rollins A.L., Fastenau P.S., Bond G.R. Obsessive and compulsive symptoms in schizophrenia. Clinical and neurocognitve correlates. Journal of Nervous and Mental Disease. 188:2000;78-83.
24. Meghani S.R., Penick E.C., Nickel E.J., Othmer E., Gabriella W.F. Jr., Powell B.J., Read M.R. Schizophrenia patients with and without OCD. 151st Annual Meeting of the American Psychiatric Association, Toronto, Ontario, Canada. 1998.
25. Parkin A. Neurosis and schizophrenia: II. Modern perspectives. Psychiatric Quarterly. 40:1966;217-235.
26. Porto L., Bermanzohn P.C., Pollack S., Morrissey R., Siris S.G. A profile of obsessive-compulsive symptoms in schizophrenia. CNS Spectrums. 2:1997;21-25.
27. Poyurovsky M., Hermesh H., Weizman A. Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients. Clinical Neuropharmacology. 19:1996;305-313.
28. Poyurovsky M., Isakov V., Harmonikov S., Modai I., Rachberger B., Schneidman M., Weizman A. Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study. International Clinical Psychopharmacology. 14:1999;95-100.
29. Poyurovsky M., Fuchs C., Weizman A. Obsessive-compusive disorder in patients with first-episode schizophrenia. American Journal of Psychiatry. 156:1999;1998-2000.
30. Poyurovsky M., Dorfman-Etrog P., Hermesh H., Munitz H., Tollefson G.D., Weizman A. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms: case series. International Clinical Psychopharmacology. 15:2000;169-175.
31. Rosen I. The clinical significance of obsessions in schizophrenia. Journal of Mental Science. 103:1956;773-785.
32. Stengel E.A. A study of some clinical aspects of the relationship between obsessional neurosis and psychotic reaction types. Journal of Mental Science. 91:1945;166-187.
33. Tibbo P., Kroetsch M., Chue P., Warneke L. Obsessive-compulsive disorder in schizophrenia. Journal of Psychiatric Research. 34:2000;139-146.
34. WHO Collaborating Center for Drug Statistics Methodology . Guidelines for Anatomical Therapeutic Chemical (ATC) Classification System. 1997;WHO Collaborating Center for Drug Statistics Methodology, Oslo.
35. Wykes T., Sturt E. The measurement of social behaviour in psychiatric patients: an assessment of the reliability and validity of the SBS schedule. British Journal of Psychiatry. 148:1986;1-11.